Disease control agents and inhibitors of plant lesions
A novel disease control agent using specific Pseudomonas cichorii strains or their culture supernatants effectively suppresses Pseudomonas cichorii-induced diseases in crops, addressing yield loss and microbial disruption concerns.
Patent Information
- Application Number
- JP2026060520
- Authority / Receiving Office
- JP · JP
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2025-05-09
- Filing Date
- 2026-04-01
- Publication Date
- 2026-11-19
AI Technical Summary
Existing methods are inadequate for effectively controlling diseases caused by the pathogenic bacterium Pseudomonas cichorii, which leads to significant yield loss in crops like lettuce, with existing solutions potentially promoting the development of resistant strains and disrupting microbial ecosystems.
A disease control agent comprising specific strains of Pseudomonas cichorii, such as NL77260, YM8302, and Pci0503, or their culture supernatants, is used to inhibit the growth of Pseudomonas cichorii strains and suppress tissue lesions in plants, offering an alternative mechanism to conventional antibiotics.
The control agent significantly reduces disease severity in plants, maintaining microbial balance and preventing the emergence of resistant strains, with efficacy demonstrated through reduced tissue browning and bacterial proliferation.
Smart Images

Figure 2026182756000003 
Figure 2026182756000004 
Figure 2026182756000005
Abstract
Description
Technical Field
[0001] The present invention relates to a disease control agent and a plant lesion inhibitor.
Background Art
[0002] Pseudomonas cichorii (P. cichorii) is a polyphagous plant pathogenic bacterium that causes diseases in many plants. Specifically, P. cichorii is known to be a causative bacterium of diseases in lettuce, melon, tomato, soybean, chrysanthemum, eggplant and the like (for example, Non-Patent Documents 1 to 2). In particular, lettuce infected with these bacteria causes rot, and the yield is reduced by up to 40%.
[0003] Patent Document 1 discloses, for example, a method for controlling rot caused by Pseudomonas cichorii as a pathogenic bacterium, which comprises treating plants with Pseudomonas fluorescens bacteria. In addition, Patent Document 2 discloses, for example, a plant disease control agent containing, as an active ingredient, a microorganism belonging to Clostridium butyricum and exhibiting antibacterial activity against plant pathogenic filamentous fungi including Fusarium oxysporum and plant pathogenic bacteria including Pseudomonas cichorii.
Prior Art Documents
Patent Documents
[0004]
Patent Document 1
Patent Document 2
Non-Patent Documents
[0005]
Non-Patent Document 1
[0006] The present invention aims to provide a control agent for diseases caused by the novel pathogen Pseudomonas cichorii. [Means for solving the problem]
[0007] The inventors have found that inoculating lettuce plants with a combination of suspensions of Pseudomonas cichorii strain NL77255 and Pseudomonas cichorii strain NL77260, Pseudomonas cichorii strain NL77255 and Pseudomonas cichorii strain YM8302, or Pseudomonas cichorii strain NL77255 and Pseudomonas cichorii strain Pci0503 can suppress tissue lesions (tissue browning) caused by infection with each strain. Furthermore, it was found that diseases caused by Pseudomonas cichorii infection in lettuce plants can be similarly suppressed by using Pseudomonas cichorii strains TUA7601, TUA7602, TUA7603, TUA7604, TUA7607, TUA7608, TUA7610, NL78107, Pseudomonas sp. NL77245, Pseudomonas sp. Pci9703, or Pseudomonas cichorii TUA7605 instead of Pseudomonas cichorii strain NL77255. This invention is based on these novel findings.
[0008] The present invention provides, for example, the following inventions: [1-A] A control agent for diseases caused by the pathogen Pseudomonas cichorii, One or more bacterial cells selected from the group consisting of Pseudomonas cichorii strain NL77260 (accession number: NITE P-04366), Pseudomonas cichorii strain YM8302 (accession number: NITE P-04367), and Pseudomonas cichorii strain Pci0503 (accession number: NITE P-04368), or their culture supernatant, Pseudomonas cichorii NL77255 strain (Accession number: NITE P-04379), Pseudomonas cichorii TUA7601 strain (Accession number: NITE P-04534), Pseudomonas cichorii TUA7602 strain (Accession number: NITE P-04535), Pseudomonas cichorii TUA7603 strain (Accession number: NITE P-04536), Pseudomonas cichorii TUA7604 strain (Accession number: NITE P-04537), Pseudomonas cichorii TUA7607 strain (Accession number: NITE P-04538), Pseudomonas cichorii TUA7608 strain (Accession number: NITE P-04539), Pseudomonas cichorii A control agent comprising one or more fungal cells selected from the group consisting of Pseudomonas cichorii strain TUA7610 (accession number: NITE P-04540), Pseudomonas cichorii strain NL78107 (accession number: NITE P-04532), Pseudomonas sp. NL77245 (accession number: NITE P-04531), Pseudomonas sp. Pci9703 (accession number: NITE P-04533), and Pseudomonas cichorii strain TUA7605 (accession number: NITE P-04369), or its culture supernatant. [1-B] A control agent for diseases caused by the pathogen Pseudomonas cichorii, One or more bacterial cells selected from the group consisting of Pseudomonas cichorii strain NL77260 (accession number: NITE P-04366), Pseudomonas cichorii strain YM8302 (accession number: NITE P-04367), and Pseudomonas cichorii strain Pci0503 (accession number: NITE P-04368), or their culture supernatant, A control agent comprising the cells or culture supernatant of Pseudomonas cichorii strain NL77255 (accession number: NITE P-04379). [2-A] An inhibitor of plant lesions caused by infection with Pseudomonas cichorii, One or more bacterial cells selected from the group consisting of Pseudomonas cichorii strain NL77260 (accession number: NITE P-04366), Pseudomonas cichorii strain YM8302 (accession number: NITE P-04367), and Pseudomonas cichorii strain Pci0503 (accession number: NITE P-04368), or their culture supernatant, Pseudomonas cichorii NL77255 strain (Accession number: NITE P-04379), Pseudomonas cichorii TUA7601 strain (Accession number: NITE P-04534), Pseudomonas cichorii TUA7602 strain (Accession number: NITE P-04535), Pseudomonas cichorii TUA7603 strain (Accession number: NITE P-04536), Pseudomonas cichorii TUA7604 strain (Accession number: NITE P-04537), Pseudomonas cichorii TUA7607 strain (Accession number: NITE P-04538), Pseudomonas cichorii TUA7608 strain (Accession number: NITE P-04539), Pseudomonas cichorii An inhibitor comprising one or more bacterial cells selected from the group consisting of TUA7610 strain (accession number: NITE P-04540), Pseudomonas cichorii NL78107 strain (accession number: NITE P-04532), Pseudomonas sp. NL77245 strain (accession number: NITE P-04531), Pseudomonas sp. Pci9703 strain (accession number: NITE P-04533), and Pseudomonas cichorii TUA7605 strain (accession number: NITE P-04369), or the culture supernatant thereof. [2-B] An inhibitor of plant lesions caused by infection with Pseudomonas cichorii, One or more bacterial cells selected from the group consisting of Pseudomonas cichorii strain NL77260 (accession number: NITE P-04366), Pseudomonas cichorii strain YM8302 (accession number: NITE P-04367), and Pseudomonas cichorii strain Pci0503 (accession number: NITE P-04368), or their culture supernatant, An inhibitor comprising the bacterial cells or culture supernatant of Pseudomonas cichorii strain NL77255 (accession number: NITE P-04379). [3] The inhibitor described in [2-A] or [2-B], wherein the above-mentioned lesion is a lesion occurring in lettuce plants. [4] The inhibitor according to [2-A], [2-B], or [3], wherein the above-mentioned lesion occurs on the leaves of a lettuce plant. [5-A] A method for controlling diseases caused by the pathogen Pseudomonas cichorii, One or more bacterial cells selected from the group consisting of Pseudomonas cichorii strain NL77260 (accession number: NITE P-04366), Pseudomonas cichorii strain YM8302 (accession number: NITE P-04367), and Pseudomonas cichorii strain Pci0503 (accession number: NITE P-04368), or their culture supernatant, Pseudomonas cichorii NL77255 strain (Accession number: NITE P-04379), Pseudomonas cichorii TUA7601 strain (Accession number: NITE P-04534), Pseudomonas cichorii TUA7602 strain (Accession number: NITE P-04535), Pseudomonas cichorii TUA7603 strain (Accession number: NITE P-04536), Pseudomonas cichorii TUA7604 strain (Accession number: NITE P-04537), Pseudomonas cichorii TUA7607 strain (Accession number: NITE P-04538), Pseudomonas cichorii TUA7608 strain (Accession number: NITE P-04539), Pseudomonas cichorii A method comprising inoculating a plant with one or more fungal cells selected from the group consisting of Pseudomonas cichorii strain TUA7610 (accession number: NITE P-04540), Pseudomonas cichorii strain NL78107 (accession number: NITE P-04532), Pseudomonas sp. NL77245 (accession number: NITE P-04531), Pseudomonas sp. Pci9703 (accession number: NITE P-04533), and Pseudomonas cichorii strain TUA7605 (accession number: NITE P-04369), or the culture supernatant thereof. [5-B] A method for controlling diseases caused by the pathogen Pseudomonas cichorii, One or more bacterial cells selected from the group consisting of Pseudomonas cichorii strain NL77260 (accession number: NITE P-04366), Pseudomonas cichorii strain YM8302 (accession number: NITE P-04367), and Pseudomonas cichorii strain Pci0503 (accession number: NITE P-04368), or their culture supernatant, A method comprising inoculating a plant with the cells of Pseudomonas cichorii strain NL77255 (accession number: NITE P-04379) or its culture supernatant. [6-A] A method for suppressing plant lesions caused by infection with Pseudomonas cichorii, One or more bacterial cells selected from the group consisting of Pseudomonas cichorii strain NL77260 (accession number: NITE P-04366), Pseudomonas cichorii strain YM8302 (accession number: NITE P-04367), and Pseudomonas cichorii strain Pci0503 (accession number: NITE P-04368), or their culture supernatant, Pseudomonas cichorii NL77255 strain (Accession number: NITE P-04379), Pseudomonas cichorii TUA7601 strain (Accession number: NITE P-04534), Pseudomonas cichorii TUA7602 strain (Accession number: NITE P-04535), Pseudomonas cichorii TUA7603 strain (Accession number: NITE P-04536), Pseudomonas cichorii TUA7604 strain (Accession number: NITE P-04537), Pseudomonas cichorii TUA7607 strain (Accession number: NITE P-04538), Pseudomonas cichorii TUA7608 strain (Accession number: NITE P-04539), Pseudomonas cichorii A method comprising inoculating a plant with one or more fungal cells selected from the group consisting of Pseudomonas cichorii strain TUA7610 (accession number: NITE P-04540), Pseudomonas cichorii strain NL78107 (accession number: NITE P-04532), Pseudomonas sp. NL77245 (accession number: NITE P-04531), Pseudomonas sp. Pci9703 (accession number: NITE P-04533), and Pseudomonas cichorii strain TUA7605 (accession number: NITE P-04369), or the culture supernatant thereof. [6-B] A method for suppressing plant lesions caused by infection with Pseudomonas cichorii, One or more bacterial cells selected from the group consisting of Pseudomonas cichorii strain NL77260 (accession number: NITE P-04366), Pseudomonas cichorii strain YM8302 (accession number: NITE P-04367), and Pseudomonas cichorii strain Pci0503 (accession number: NITE P-04368), or a culture supernatant thereof, and a bacterial cell of Pseudomonas cichorii strain NL77255 (accession number: NITE P-04379) or a culture supernatant thereof are inoculated into a plant. [7] The method according to [6-A] or [6-B], wherein the lesion is a lesion that occurs in a lettuce plant. [8] The method according to [6-A], [6-B], or [7], wherein the lesion is a lesion that occurs on the leaf of a lettuce plant. [Effects of the Invention]
[0009] According to the present invention, it is possible to provide a novel control agent for diseases caused by Pseudomonas cichorii as a pathogenic bacterium. [Brief Description of the Drawings]
[0010] [Figure 1] This is a diagram showing the results of evaluating the growth inhibitory effect on each Pseudomonas cichorii strain by dropping the high-molecular fraction of the culture supernatant of strain NL77260, strain YM8302, strain Pci0503, or strain NL77255 onto an agar medium overlaid with various Pseudomonas cichorii. [Figure 2] This is a diagram showing the results of evaluating tissue browning of the leaves of lettuce plants (Cisco variety) when inoculated with a specific strain of Pseudomonas cichorii alone or in combination. [Figure 3] This is a diagram showing the results of evaluating tissue browning of the leaves of lettuce plants (Souther variety) when inoculated with a specific strain of Pseudomonas cichorii alone or in combination. [Figure 4] This figure shows the results of evaluating the browning of lettuce leaves when lettuce plants (V lettuce varieties) were inoculated with specific strains of Pseudomonas cichorii, either alone or in combination. [Figure 5] This figure shows the results of evaluating the effect of adding a specific culture supernatant of Pseudomonas cichorii, cultured after being treated with mitomycin C, on the growth inhibitory effect of each Pseudomonas cichorii strain on an agar plate overlaid with a specific strain of Pseudomonas cichorii. [Figure 6] This graph shows the number of viable bacteria in lettuce leaves when a specific strain of fungus was inoculated into the lettuce plant, either individually or in combination. [Figure 7] In Test Example 5, the molecular phylogenetic tree was constructed based on the whole genome sequence information of the bacterial strain. [Figure 8] This graph shows the relative proportions of each fungal strain in the leaves of lettuce plants after they have been inoculated with specific strains. [Figure 9] This table shows the control efficacy and bactericidal activity of the high molecular weight fraction of the culture supernatant when lettuce plants are inoculated with a combination of specific fungal strains. [Modes for carrying out the invention]
[0011] The following describes in detail embodiments for carrying out the present invention. However, the present invention is not limited to the following embodiments.
[0012] Hereafter, "Pseudomonas cichorii XXXXXX strain" or "Pseudomonas sp. XXXXXX strain" will also be simply referred to as "XXXXXX strain." For example, Pseudomonas cichorii NL77255 strain will simply be referred to as "NL77255 strain."
[0013] [Disease control agents] The disease control agent according to this embodiment is a disease control agent for diseases caused by P. cichorii, and comprises one or more bacterial cells (bacterial group A) selected from the group consisting of strains NL77260, YM8302, and Pci0503, or their culture supernatant, and one or more bacterial cells (bacterial group B) selected from the group consisting of strains NL77255, TUA7601, TUA7602, TUA7603, TUA7604, TUA7607, TUA7608, TUA7610, NL78107, NL77245, Pci9703, and TUA7605, or their culture supernatant.
[0014] The disease control agent according to this embodiment is a disease control agent for diseases caused by P. cichorii, and may include one or more bacterial cells or their culture supernatant selected from the group consisting of strains NL77260, YM8302, and Pci0503, and bacterial cells or their culture supernatant of strain NL77255.
[0015] The bacterial cells or culture supernatant contained in the disease control agent according to this embodiment may be two or more, or even three, selected from the group consisting of NL77260 strain, YM8302 strain, and Pci0503 strain (bacterial cell group A).
[0016] The disease control agent according to this embodiment may contain one or more bacterial cells (bacterial cell group B) selected from the group consisting of NL77255 strain, TUA7601 strain, TUA7602 strain, TUA7603 strain, TUA7604 strain, TUA7607 strain, TUA7608 strain, TUA7610 strain, NL78107 strain, NL77245 strain, Pci9703 strain, and TUA7605 strain, or its culture supernatant, which may consist of two or more, three or more, four or more, five or more, six or more, seven or more, eight or more, nine or more, ten or more, eleven or more, or twelve types selected from the above group.
[0017] As shown in the examples described below, it was found that the high molecular weight fractions of the culture supernatants of strains NL77260, YM8302, and Pci0503 inhibited the growth of various P. cichorii strains, including strain NL77255. Therefore, it is thought that strains NL77260, YM8302, and Pci0503 secrete substances (for example, substances with bactericidal or bacteriostatic effects) that inhibit the growth of P. cichorii, including strain NL77255.
[0018] Furthermore, it was found that the high molecular weight fraction of the culture supernatant of strain NL77255 inhibited the growth of various P. cichorii strains, including strains NL77260, YM8302, and Pci0503. Therefore, it is thought that strain NL77255 secretes a substance (for example, a bactericidal or bacteriostatic substance) that inhibits the growth of P. cichorii, including strains NL77260, YM8302, and Pci0503.
[0019] Furthermore, as described later, inoculating lettuce plants with a combination of the fungal cells of strains NL77260, YM8302, and Pci0503, along with the fungal cells of strain NL77255, suppresses the browning of lettuce leaves caused by P. cichorii infection. From these findings, it is considered that the disease control agent according to this embodiment can control diseases caused by P. cichorii. In addition, it was confirmed that inoculating lettuce plants with a combination of fungal cells from strains NL77260, YM8302, or Pci0503 and fungal cells from strains NL77255, TUA7601, TUA7602, TUA7603, TUA7604, TUA7607, TUA7608, TUA7610, NL78107, NL77245, Pci9703, or TUA7605 can control diseases of lettuce plants caused by P. cichorii infection.
[0020] In this specification, "control of diseases caused by P. cichorii" means preventing plants from becoming infected with P. cichorii, or suppressing disease development even if infected (disease suppression). Whether or not diseases caused by P. cichorii are being controlled can be determined by methods known to those skilled in the art, for example, based on the presence or absence and proliferation rate of P. cichorii in the plants, and the presence and degree of disease symptoms in the plants (e.g., tissue browning in the plants).
[0021] The disease control agent according to this embodiment can control diseases through a mechanism different from that of conventional antibiotics, thus reducing the emergence of resistant strains. Furthermore, since it is not effective against all microorganisms, it can prevent disruption of the microbial ecosystem.
[0022] The control agent according to this embodiment may have a disease severity of, for example, 50 or less, 40 or less, 30 or less, 20 or less, or 15 or less when the agent is used. In this specification, "disease severity" refers to the degree calculated by the following formula (1). The disease severity index is "0" if there is no tissue browning, "1" if there is tissue browning of more than 0% but less than or equal to 50%, and "2" if there is tissue browning of 50% or more. Formula (1): Disease severity = {Σ(disease index × number of leaves per index)} × 100 / (2 × number of leaves surveyed)
[0023] The control agent according to this embodiment may have a control value of, for example, 40 or more, or 50 or more, when used. The control value refers to the value obtained when the control agent according to this embodiment is applied to plants at the same time as inoculation with the pathogen, or before inoculation with the pathogen (for example, 1 hour to several days prior). In this specification, "control value" means the value calculated by the following formula (2). Equation (2): Control value = (100 - disease severity with mixed inoculation / disease severity with single inoculation) × 100
[0024] Diseases caused by P. cichorii include, for example, rot, bacterial brown spot, and bacterial leaf spot.
[0025] In this specification, unless otherwise specified, “plant” means all organs of a plant, including the whole or a part of it, such as flowers (including buds), shoots, leaves, stems, roots, rhizomes, tubers, and rhizomes.
[0026] In this embodiment, the plant targeted for disease control may be at least one plant selected from the group consisting of, for example, lettuce (Lactuca sativa), melon (Cucumis melo), tomato (Solanum lycopersicum), soybean (Glycine max), chrysanthemum (Chrysanthemum morifolium), eggplant (Solanum melongena), onion (Allium cepa), cucumber (Cucumis sativus), cabbage (Brassica oleracea var. capitata), broccoli (Brassica oleracea var. italica), and apple (Malus domestica), with lettuce being preferred.
[0027] Pseudomonas cichorii strain NL77260 is deposited with the Patent Microorganism Depository Center of the National Institute of Technology and Evaluation (NPMD) (2-5-8 Kazusa-Kamatari, Kisarazu City, Chiba Prefecture 292-0818, Japan), with accession number NITE P-04366 (deposit date: April 15, 2025).
[0028] Pseudomonas cichorii strain YM8302 is deposited with the Patent Microorganism Depository Center of the National Institute of Technology and Evaluation (NPMD) (2-5-8 Kazusa-Kamatari, Kisarazu City, Chiba Prefecture 292-0818, Japan), with accession number NITE P-04367 (deposit date: April 15, 2025).
[0029] Pseudomonas cichorii strain Pci0503 is deposited with the Patent Microorganism Depository Center of the National Institute of Technology and Evaluation (NPMD) (2-5-8 Kazusa-Kamatari, Kisarazu City, Chiba Prefecture 292-0818, Japan), with accession number NITE P-04368 (deposit date: April 15, 2025).
[0030] Pseudomonas cichorii strain NL77255 is deposited with the Patent Microorganism Depository Center of the National Institute of Technology and Evaluation (NPMD) (2-5-8 Kazusa-Kamatari, Kisarazu City, Chiba Prefecture 292-0818, Japan), with accession number NITE P-04379 (deposit date: April 25, 2025).
[0031] Pseudomonas cichorii strain TUA7601 is deposited with the Patent Microorganism Depository Center of the National Institute of Technology and Evaluation (NPMD) (2-5-8 Kazusa-Kamatari, Kisarazu City, Chiba Prefecture 292-0818, Japan), with accession number NITE P-04534 (deposit date: February 19, 2026).
[0032] Pseudomonas cichorii strain TUA7602 is deposited with the Patent Microorganism Depository Center of the National Institute of Technology and Evaluation (NPMD) (2-5-8 Kazusa-Kamatari, Kisarazu City, Chiba Prefecture 292-0818, Japan), with accession number NITE P-04535 (deposit date: February 19, 2026).
[0033] Pseudomonas cichorii strain TUA7603 is deposited with the Patent Microorganism Depository Center of the National Institute of Technology and Evaluation (NPMD) (2-5-8 Kazusa-Kamatari, Kisarazu City, Chiba Prefecture 292-0818, Japan), with accession number NITE P-04536 (deposit date: February 19, 2026).
[0034] Pseudomonas cichorii strain TUA7604 is deposited with the Patent Microorganism Depository Center of the National Institute of Technology and Evaluation (NPMD) (2-5-8 Kazusa-Kamatari, Kisarazu City, Chiba Prefecture 292-0818, Japan), with accession number NITE P-04537 (deposit date: February 19, 2026).
[0035] Pseudomonas cichorii strain TUA7607 is deposited with the Patent Microorganism Depository Center of the National Institute of Technology and Evaluation (NPMD) (2-5-8 Kazusa-Kamatari, Kisarazu City, Chiba Prefecture 292-0818, Japan), with accession number NITE P-04538 (deposit date: February 19, 2026).
[0036] Pseudomonas cichorii strain TUA7608 is deposited with the Patent Microorganism Depository Center of the National Institute of Technology and Evaluation (NPMD) (2-5-8 Kazusa-Kamatari, Kisarazu City, Chiba Prefecture 292-0818, Japan), with accession number NITE P-04539 (deposit date: February 19, 2026).
[0037] Pseudomonas cichorii strain TUA7610 is deposited with the Patent Microorganism Depository Center of the National Institute of Technology and Evaluation (NPMD) (2-5-8 Kazusa-Kamatari, Kisarazu City, Chiba Prefecture 292-0818, Japan), with accession number NITE P-04540 (deposit date: February 19, 2026).
[0038] Pseudomonas cichorii strain NL78107 is deposited with the Patent Microorganism Depository Center of the National Institute of Technology and Evaluation (NPMD) (2-5-8 Kazusa-Kamatari, Kisarazu City, Chiba Prefecture 292-0818, Japan), with accession number NITE P-04532 (deposit date: February 19, 2026).
[0039] Pseudomonas sp. (NL77245 strain) is deposited with the Patent Microorganism Depository Center of the National Institute of Technology and Evaluation (NPMD) (2-5-8 Kazusa-Kamatari, Kisarazu City, Chiba Prefecture 292-0818, Japan), with accession number NITE P-04531 (deposit date: February 19, 2026).
[0040] Pseudomonas sp. (Pseudomonas sp.) strain Pci9703 is deposited with the Patent Microorganism Depository Center of the National Institute of Technology and Evaluation (NPMD) (2-5-8 Kazusa-Kamatari, Kisarazu City, Chiba Prefecture 292-0818, Japan), with accession number NITE P-04533 (deposit date: February 19, 2026).
[0041] Pseudomonas cichorii strain TUA7605 is deposited with the Patent Microorganism Depository Center of the National Institute of Technology and Evaluation (NPMD) (2-5-8 Kazusa-Kamatari, Kisarazu City, Chiba Prefecture 292-0818, Japan), with accession number NITE P-04369 (deposit date: April 15, 2025).
[0042] If the disease control agent according to this embodiment contains the culture supernatant of the P. cichorii strain or the Pseudomonas sp. strain, the culture supernatant may be the high-molecular-weight fraction of the culture supernatant of the P. cichorii strain or the Pseudomonas sp. strain. The high-molecular-weight fraction of the culture supernatant means the fraction in the culture supernatant with a molecular weight of 50,000 or more. The high-molecular-weight fraction of the culture supernatant can be obtained, for example, by ultrafiltration of the culture supernatant using an Amicon Ultra-15 centrifugal filter unit (Merck Millipore).
[0043] The disease control agent according to this embodiment may consist only of the cells of the above-mentioned P. cichorii strain or Pseudomonas sp. strain or its culture supernatant, or it may also contain a carrier, excipient, surfactant, binder, dispersant, thickener, preservative, antioxidant, pH adjuster, organic acid, amino acid, salt, colorant, fragrance, etc., and may also contain a culture medium on which the above-mentioned P. cichorii strain or Pseudomonas sp. strain was cultured. The disease control agent according to this embodiment may contain live or dead cells of the above-mentioned P. cichorii strain or Pseudomonas sp. strain, and it is preferable that it contains live cells. The disease control agent according to this embodiment may also contain microorganisms other than the above-mentioned P. cichorii strain and Pseudomonas sp. strain. The disease control agent according to this embodiment may be a culture of the above-mentioned P. cichorii strain or Pseudomonas sp. strain used as is, or it may be a culture of the fungal cells isolated after culturing, or it may be a dried culture or fungal cells.
[0044] The amount of the P. cichorii strain or the Pseudomonas sp. strain or its culture supernatant contained in the disease control agent according to this embodiment may be, for example, 0.001% by mass or more, 0.01% by mass or more, 0.1% by mass or more, 1% by mass or more, 5% by mass or more, 10% by mass or more, 20% by mass or more, 30% by mass or more, 50% by mass or more, 70% by mass or more, 80% by mass or more, 90% by mass or more, 95% by mass or more, or 99% by mass or more, and may also be 100% by mass or less, 99% by mass or less, 95% by mass or less, 90% by mass or less, 80% by mass or less, 70% by mass or less, 50% by mass or less, 30% by mass or less, 20% by mass or less, 10% by mass or less, 5% by mass or less, 1% by mass or less, or 0.1% by mass or less.
[0045] If the disease control agent according to this embodiment contains one or more fungal cells (fungal cell group A) selected from the group consisting of strains NL77260, YM8302, and Pci0503, and one or more fungal cells (fungal cell group B) selected from the group consisting of strains NL77255, TUA7601, TUA7602, TUA7603, TUA7604, TUA7607, TUA7608, TUA7610, NL78107, NL77245, Pci9703, and TUA7605, then the content ratio of these (content of fungal cells in fungal cell group A: content of fungal cells in fungal cell group B) is, for example, 0.1:50~50:0.1, 1:5~5:1, or 1:3~3:1.
[0046] When the disease control agent according to this embodiment contains the culture supernatant of one or more strains (bacterial group A) selected from the group consisting of strains NL77260, YM8302, and Pci0503, and the culture supernatant of one or more strains (bacterial group B) selected from the group consisting of strains NL77255, TUA7601, TUA7602, TUA7603, TUA7604, TUA7607, TUA7608, TUA7610, NL78107, NL77245, Pci9703, and TUA7605, the content ratio of these (content of culture supernatant of bacterial group A: content of culture supernatant of bacterial group B) is, for example, 0.1:50~50:0.1, 1:5~5:1, or 1:3~3:1.
[0047] When the disease control agent according to this embodiment contains one or more fungal cells selected from the group consisting of strains NL77260, YM8302, and Pci0503 (fungal cell group A) and one or more culture supernatants selected from the group consisting of strains NL77255, TUA7601, TUA7602, TUA7603, TUA7604, TUA7607, TUA7608, TUA7610, NL78107, NL77245, Pci9703, and TUA7605 (fungal cell group B), the content ratio of these (content of fungal cells of bacterial cell group A: content of culture supernatant of bacterial cell group B) is, for example, 0.1:50 to 0.2:30, or 0.5:25 to 1:20.
[0048] If the disease control agent according to this embodiment contains the culture supernatant of one or more strains (bacterial group A) selected from the group consisting of strains NL77260, YM8302, and Pci0503, and one or more bacterial cells (bacterial group B) selected from the group consisting of strains NL77255, TUA7601, TUA7602, TUA7603, TUA7604, TUA7607, TUA7608, TUA7610, NL78107, NL77245, Pci9703, and TUA7605, then the content ratio of these (content of culture supernatant of bacterial group A: content of bacterial cells of bacterial group B) is, for example, 0.1:50 to 0.2:30, or 0.5:25 to 1:20.
[0049] Regarding the substances having bactericidal or bacteriostatic effects described above, the present inventors have previously discovered the bacterium NB6, which suppresses the onset of bacterial diseases in rice, and have revealed that it secretes a bactericidal substance called teirosin (Japanese Patent Publication No. 2025-018897). Teirosin is a type of antimicrobial substance (bacteriocin) produced by bacteria, and is a tubular phage-like particle (phage tail-like bacteriocin) lacking the head of a bacteriophage. Considering these technical matters, the substance that inhibits the growth of the above-mentioned P. cichorii strain may also be teirosin. Furthermore, as shown in the examples described later, the inhibitory effect on P. cichorii growth of the culture supernatant of the above-mentioned P. cichorii strain was improved by treatment with mitomycin C, therefore, the substance that inhibits the growth of P. cichorii secreted by the above-mentioned P. cichorii strain may be teirosin derived from a phage whose production is induced by mitomycin C.
[0050] The disease control agent according to this embodiment may include teirosin derived from one or more strains selected from the group consisting of strain NL77260, strain YM8302, and strain Pci0503, and teirosin derived from one or more strains selected from the group consisting of strain NL77255, strain TUA7601, strain TUA7602, strain TUA7603, strain TUA7604, strain TUA7607, strain TUA7608, strain TUA7610, strain NL78107, strain NL77245, strain Pci9703, and strain TUA7605.
[0051] The form of the disease control agent in this embodiment is not particularly limited and may be, for example, a liquid, solid, gel, paste, etc., and can be appropriately set depending on the usage situation.
[0052] [Inhibitors for plant disease] As described above, the disease control agent according to this embodiment may also be a plant lesion inhibitor. The plant lesion inhibitor according to this embodiment is a plant lesion inhibitor caused by infection with P. cichorii and comprises one or more fungal cells or their culture supernatant selected from the group consisting of strains NL77260, YM8302, and Pci0503, and one or more fungal cells or their culture supernatant selected from the group consisting of strains NL77255, TUA7601, TUA7602, TUA7603, TUA7604, TUA7607, TUA7608, TUA7610, NL78107, NL77245, Pci9703, and TUA7605.
[0053] The plant lesion inhibitor according to this embodiment is an inhibitor of plant lesions caused by infection with P. cichorii, and may include one or more bacterial cells or their culture supernatant selected from the group consisting of strains NL77260, YM8302, and Pci0503, and bacterial cells or their culture supernatant of strain NL77255.
[0054] The plant lesion inhibitor according to this embodiment only needs to suppress plant lesions caused by P. cichorii infection, and specifically, it may suppress by, for example, 1% or more, 5% or more, 10% or more, 15% or more, 20% or more, 30% or more, 40% or more, 50% or more, 60% or more, 70% or more, 80% or more, or 90% or more.
[0055] The ability of the plant lesion inhibitor according to this embodiment to suppress plant lesions caused by P. cichorii infection can be evaluated, for example, by following the methods described in the examples below. Specifically, the suppression of plant lesions caused by P. cichorii infection can be evaluated by comparing, for example, the observed value of plant lesions caused by P. cichorii infection when P. cichorii is inoculated into plants alone with the observed value of plant lesions caused by P. cichorii infection when P. cichorii and the lesion inhibitor according to this embodiment are inoculated into plants.
[0056] The lesion in question may be, for example, a lesion occurring on at least one plant selected from the group consisting of lettuce (Lactuca sativa), melon (Cucumis melo), tomato (Solanum lycopersicum), soybean (Glycine max), chrysanthemum (Chrysanthemum morifolium), eggplant (Solanum melongena), onion (Allium cepa), cucumber (Cucumis sativus), cabbage (Brassica oleracea var. capitata), broccoli (Brassica oleracea var. italica), and apple (Malus domestica). It is preferable that the lesion occurs on lettuce plants, more preferably on the leaves of lettuce plants, and even more preferably on tissue browning of the leaves of lettuce plants.
[0057] Other specific embodiments can be applied that are similar to those of the disease control agent according to the present embodiment described above.
[0058] [Growth inhibitors] As described above, strains NL77260, YM8302, Pci0503, and NL77255 are thought to secrete substances that inhibit the growth of P. cichorii strains. Furthermore, using one or more bacterial cells or their culture supernatant selected from the group consisting of strains NL77260, YM8302, and Pci0503, along with one or more bacterial cells or their culture supernatant selected from the group consisting of strains NL77255, TUA7601, TUA7602, TUA7603, TUA7604, TUA7607, TUA7608, TUA7610, NL78107, NL77245, Pci9703, and TUA7605, can inhibit the growth of various P. cichorii strains. Therefore, the present invention can also be considered as a growth inhibitor of P. cichorii, comprising one or more bacterial cells or their culture supernatant selected from the group consisting of strains NL77260, YM8302, and Pci0503, and one or more bacterial cells or their culture supernatant selected from the group consisting of strains NL77255, TUA7601, TUA7602, TUA7603, TUA7604, TUA7607, TUA7608, TUA7610, NL78107, NL77245, Pci9703, and TUA7605. The P. cichorii whose growth is inhibited is the same as the P. cichorii as the pathogen being controlled. As for other specific embodiments, embodiments similar to those of the disease control agent according to the present embodiment described above can be applied.
[0059] [Methods for controlling diseases] The disease control method according to this embodiment is a method for controlling diseases caused by P. cichorii as the pathogen, One or more bacterial cells selected from the group consisting of strains NL77260, YM8302, and Pci0503, or their culture supernatant, This method involves inoculating a plant with one or more fungal cells or their culture supernatant selected from the group consisting of strains NL77255, TUA7601, TUA7602, TUA7603, TUA7604, TUA7607, TUA7608, TUA7610, NL78107, NL77245, Pci9703, and TUA7605.
[0060] As described above, P. cichorii, the pathogen of the disease to be controlled, and strains NL77260, YM8302, Pci0503, NL77255, TUA7601, TUA7602, TUA7603, TUA7604, TUA7607, TUA7608, TUA7610, NL78107, NL77245, Pci9703, and TUA7605 are as described above. The plants to be inoculated may be as described for the plants that are targeted for disease control.
[0061] Methods for inoculating plants with the cells or culture supernatant of the above-mentioned P. cichorii strain include, for example, administering (injecting) the cells by extruding them into the plant using a syringe or needle, immersing the plant in a suspension or culture supernatant of the above-mentioned P. cichorii strain, or applying and / or spraying the suspension or culture supernatant of the above-mentioned P. cichorii strain or the above-mentioned Pseudomonas sp. strain onto the surface of the plant (or, in some cases, making a wound on the surface of the plant and applying the wound to the wounded area). Administering (injecting) the cells or culture supernatant by extruding them into the plant using a syringe or needle is preferred.
[0062] In the disease control method according to this embodiment, one or more fungal cells selected from the group consisting of strains NL77260, YM8302, and Pci0503 are, for example, OD 600 The bacterial cells may be inoculated at a cell concentration of 0.001 to 0.5, 0.002 to 0.2, or 0.004 to 0.1. The culture supernatant of the above bacterial cells may also be inoculated with the culture supernatant of a culture medium at a cell concentration of 0.2 to 10, 0.4 to 9, 0.6 to 8, 0.8 to 7, 1 to 6, or 2 to 5.
[0063] In the disease control method according to this embodiment, one or more fungal cells selected from the group consisting of strains NL77255, TUA7601, TUA7602, TUA7603, TUA7604, TUA7607, TUA7608, TUA7610, NL78107, NL77245, Pci9703, and TUA7605 are, for example, OD 600 The bacterial cells may be inoculated at a cell concentration of 0.001 to 0.5, 0.002 to 0.2, or 0.004 to 0.1. The culture supernatant of the above bacterial cells may also be inoculated with the culture supernatant of a culture medium at a cell concentration of 0.2 to 10, 0.4 to 9, 0.6 to 8, 0.8 to 7, 1 to 6, or 2 to 5.
[0064] As a specific embodiment of the disease control method according to this embodiment, the lesion inhibitor according to this embodiment described above and embodiments similar to the lesion inhibitor according to this embodiment can be applied.
[0065] [Methods for suppressing plant diseases] The disease control method according to this embodiment can also be described as a method for suppressing plant lesions. The method for suppressing plant lesions according to this embodiment is a method for suppressing plant lesions caused by infection with P. cichorii, and includes inoculating plants with one or more fungal cells or their culture supernatant selected from the group consisting of strains NL77260, YM8302, and Pci0503, and one or more fungal cells or their culture supernatant selected from the group consisting of strains NL77255, TUA7601, TUA7602, TUA7603, TUA7604, TUA7607, TUA7608, TUA7610, NL78107, NL77245, Pci9703, and TUA7605.
[0066] Other specific embodiments of the plant disease suppression method according to this embodiment can be applied in the same manner as the disease suppressant and disease control method according to this embodiment described above.
[0067] [Growth suppression method] The present invention can also be understood as a method for suppressing the growth of P. cichorii, comprising inoculating plants with one or more fungal cells or their culture supernatant selected from the group consisting of strains NL77260, YM8302, and Pci0503, and one or more fungal cells or their culture supernatant selected from the group consisting of strains NL77255, TUA7601, TUA7602, TUA7603, TUA7604, TUA7607, TUA7608, TUA7610, NL78107, NL77245, Pci9703, and TUA7605. The P. cichorii whose growth is suppressed is the same as the P. cichorii as the pathogen being controlled. Other specific embodiments of the growth suppression method according to this embodiment can be applied in the same manner as the lesion inhibitor and disease control method according to this embodiment described above. [Examples]
[0068] The present invention will be described more specifically below based on examples. However, the present invention is not limited to the following examples.
[0069] [Test Example 1: Evaluation of Growth Inhibition Effect] First, high molecular weight fractions were obtained from the culture supernatants (after removing viable cells by centrifugation and filter filtration) of 34 Pseudomonas cichorii strains, including Pseudomonas cichorii strain NL77260, Pseudomonas cichorii strain YM8302, Pseudomonas cichorii strain Pci0503, and Pseudomonas cichorii strain NL77255, using the following procedure. The culture supernatants were ultrafiltered using an Amicon Ultra-15 centrifugal filter unit (Merck Millipore) to obtain the high molecular weight fractions. Solutions were prepared by diluting each of the obtained high molecular weight fractions 10-fold, 100-fold, 1000-fold, or 10000-fold using TN50 (50 nM NaCl, 10 mM Tris-HCl, pH 7.5).
[0070] The growth inhibitory effect of the high-molecular-weight fraction of each culture supernatant on each strain was evaluated by dropping the high-molecular-weight fraction of the culture supernatant onto agar plates overlaid with strains #73-#76, strain #103, strains #78-81, strain NL77255, strain NL77260, strains #84-#85, strain YM8302, strain #10, or strain Pci0503, and culturing overnight at 30°C. Note that "#XX" in the strains labeled #XX is a sequential number assigned by the inventors to specific strains of Pseudomonas cichorii. Some of the results are shown in Figure 1.
[0071] As shown in Figure 1, when the high molecular weight fraction of the culture supernatant of strain NL77255 was dropped onto an agar medium overlaid with strains #73, NL77260, YM8302, #10, or Pci0503, a zone of inhibition was formed. In other words, the high molecular weight fraction of the culture supernatant of strain NL77255 inhibited the growth of strains #73, NL77260, YM8302, #10, or Pci0503.
[0072] Furthermore, as shown in Figure 1, when the high molecular weight fraction of the culture supernatant of strain NL77260 or strain YM8302 was dropped onto an agar medium containing strains #73-#76, strain #103, strains #78-81, strain NL77255, strains #84-#85, and strain #10, a zone of inhibition was formed. In other words, the high molecular weight fraction of the culture supernatant of strain NL77260 or strain YM8302 inhibited the growth of strains #73-#76, strain #103, strains #78-81, strain NL77255, strains #84-#85, and strain #10. When the high molecular weight fraction of the culture supernatant of strain Pci0503 was dropped onto agar plates overlaid with strains #73-#76, strain #103, strains #78-#79, strain #81, strain NL77255, strains #84-#85, or strain #10, a zone of inhibition was formed. In other words, the high molecular weight fraction of the culture supernatant of strain Pci0503 inhibited the growth of strains #73-#76, strain #103, strains #78-#79, strain #81, strain NL77255, strains #84-#85, or strain #10.
[0073] [Test Example 2: Evaluation of the effect of suppressing tissue browning] A suspension containing strains NL77260, YM8302, or Pci0503, and NL77255 was injected into three varieties of lettuce plants (Cisco, Souther, or V-lettuce), and the tissue browning of each lettuce plant was visually evaluated after 5 to 7 days.
[0074] Suspension of NL77260 strain, YM8302 strain, Pci0503 strain, or NL77255 strain is OD 600 The suspensions were adjusted to a concentration of 0.1. The prepared suspensions were inoculated onto the leaves of lettuce plants using a syringe, either individually or in combination with the suspensions of strains NL77255 and NL77260, NL77255 and YM8302, or NL77255 and Pci0503. After inoculation, the lettuce plants were cultivated for 5 to 7 days in an artificial climate chamber set to 22°C with 14 hours of light. After cultivation, the degree of tissue browning in the leaves of each lettuce plant was evaluated by visual assessment. For comparison, the same experiment was also performed using sterile water instead of the above suspensions (mock). The results are shown in Figures 2 to 4.
[0075] In the objective assessment, "0" was assigned if there was no tissue browning, "1" if there was tissue browning between 0% and 50%, and "2" if there was tissue browning of 50% or more (see "index" in Figures 2-4).
[0076] As shown in Figures 2-4, when suspensions of strains NL77260, YM8302, Pci0503, or NL77255 were used individually, tissue browning was observed in lettuce leaves. On the other hand, when suspensions of strains NL77255 and NL77260, NL77255 and YM8302, or NL77255 and Pci0503 were used in combination, the observed values were lower compared to when each strain was used individually, indicating that tissue browning was suppressed.
[0077] [Test Example 3: Search for growth-inhibiting active ingredients] It is known that bacterial phage production is induced by SOS signals triggered by DNA replication inhibitors. Therefore, we observed whether the culture supernatant of each bacterial strain affected the formation of the inhibition zone when cultured with a DNA replication inhibitor (mitomycin C) added to the culture medium. Specifically, the procedure was followed.
[0078] NL77255 strain was cultured in the same manner as in Test Example 1, except that NL77260 strain, YM8302 strain, or Pci0503 strain were cultured in a liquid medium (LB medium) containing mitomycin C at a concentration of 5 micrograms / milliliter, with NL77255 strain as a top layer, and the resulting culture supernatant was added dropwise. This allowed us to evaluate the effect of the culture supernatants of NL77260 strain, YM8302 strain, or Pci0503 strain cultured in a medium containing mitomycin C on the formation of the inhibition zone of NL77255 strain. The results are shown in Figure 5.
[0079] As shown in Figure 5, treatment of strains NL77260, YM8302, or Pci0503 with mitomycin C significantly increased the formation of inhibition zones against strain NL77255 in the culture supernatants of these strains. This result suggests that the active ingredient in the culture supernatants of strains NL77260, YM8302, and Pci0503 that inhibits the growth of strain NL77255 is likely teirosin, a phage-derived compound whose production is induced by mitomycin C treatment.
[0080] [Test Example 4: Confirmation of disease suppression effect by measuring intraleaf fungal count] In the same manner as in Test Example 2, suspensions of strains NL77260, YM8302, Pci0503, or NL77255 were inoculated onto the leaves of lettuce plants using a syringe, either individually or in combination with the suspensions of strains NL77255 and NL77260, NL77255 and YM8302, or NL77255 and Pci0503. After inoculation, the lettuce plants were cultivated for 5 to 7 days in an artificial climate chamber set to 22°C with 14 hours of light. The number of bacteria in the leaves of the cultivated lettuce plants was measured. Specifically, the procedure was as follows.
[0081] Three tissue samples, including the inoculation site, were punched out from leaves 5-7 days after inoculation using a cork borer. These samples were homogenized in sterile water to obtain a suspension. The resulting suspension was serially diluted, spread onto LB agar plates, and incubated at 30°C. The number of colonies that appeared was then measured, and the number of viable bacteria per three leaf disks (Cfu / 3 leaf disks) was calculated.
[0082] Furthermore, the disease severity and control efficacy were calculated for each lettuce plant after cultivation. The disease severity was calculated using the following formula (1). The disease severity index was defined as "0" if there was no tissue browning, "1" if there was tissue browning of more than 0% but less than 50%, and "2" if there was tissue browning of 50% or more. The control efficacy was calculated using the following formula (2). Formula (1): Disease severity = {Σ(disease index × number of leaves per index)} × 100 / (2 × number of leaves surveyed) Equation (2): Control value = (100 - disease severity with mixed inoculation / disease severity with single inoculation) × 100
[0083] These results are shown in Figure 6 and Table 1.
[0084] [Table 1]
[0085] As shown in Figure 6 and Table 1, the number of bacteria when inoculated with suspensions of strains NL77255 and NL77260, NL77255 and YM8302, or NL77255 and Pci0503 was significantly reduced compared to the number of bacteria when each of the suspensions of strains NL77260, YM8302, Pci0503, or NL77255 was inoculated individually.
[0086] Furthermore, as shown in Table 1, the control titers when suspensions of strains NL77255 and NL77260, NL77255 and YM8302, or NL77255 and Pci0503 were inoculated were all significantly above 50, confirming that the disease was effectively controlled (disease suppressed).
[0087] [Example 5: Phylogenetic analysis of bacterial strains based on whole genome sequence information] The test strains included NL77255, NL77260, YM8302, and Pci0503, as well as strains #10, TUA7605, #83, #98, #99, and #17 (all P. cichorii). Genomic DNA was extracted from each strain, and the whole genome sequence was determined by long-read sequencing using the Revio system (PacBio). From the obtained genome sequence information, genes were extracted using the UBCG2 gene set, and a molecular phylogenetic tree was constructed using the maximum likelihood method with MEGA X software. The results are shown in Figure 7.
[0088] As shown in Figure 7, the results revealed that strains NL77260 and YM8302, which showed similar trends in Test Example 1 and Test Example 2, belong to very closely related clades on the phylogenetic tree. Furthermore, strain #83, which exhibited relatively high fungicidal activity (see Figure 1, etc.), was classified into the same clade as strains NL77255 and TUA7605 (see Figure 1, etc.), which also exhibited high fungicidal activity. This indicates a strong correlation between the biological characteristics (pathogenicity, control activity, etc.) exhibited by each strain and its phylogenetic position based on genomic information.
[0089] [Test Example 6: Identification of Proliferating Bacteria in Mixed Inoculation] The whole genome sequence information obtained in Test Example 5 was compared and analyzed to identify gene regions specific to strain NL77255, and gene regions common to strains NL77260, YM8302, and Pci0503 but absent in strain NL77255. Based on these regions, primer sets 1-3 capable of specifically amplifying and identifying each strain were designed and constructed. Conversely, gene regions specific to strain NL77255, and gene regions absent in strains NL77260, YM8302, and Pci0503 but present in strain NL77255 were also identified. Based on these regions, primer set 4 capable of specifically amplifying and identifying each strain was designed and constructed. The constructed primer sets are shown in Table 2. Furthermore, it was confirmed by PCR and agarose gel electrophoresis that each primer set specifically amplified only the DNA of the target strain, and did not amplify the DNA of non-target strains.
[0090] [Table 2]
[0091] In Test Example 4, 24 colonies were randomly selected from each treatment group, and DNA was extracted using the Kaneka Simple DNA Extraction Kit. PCR was performed using the extracted DNA as a template with the primer set described above, and the presence or absence of amplification by agarose gel electrophoresis was used to determine which of the bacterial strains it was. The results are shown in Figure 8.
[0092] As shown in Figure 8, in all conditions of the lettuce plants, colonies derived from strain NL77255 accounted for 50-70%, while the proportion of DNA derived from strains NL77260, YM8302, or Pci0503 was low. This result suggests that in lettuce plants, strain NL77255 proliferates dominantly and suppresses the proliferation of strains NL77260, YM8302, and Pci0503.
[0093] [Test Example 7: Confirmation of disease suppression effect by other strains] The control efficacy was calculated in the same manner as in Test Example 4, except that the test strain was changed. In addition, the growth inhibitory effect (bactericidal activity) of the high molecular weight fraction of the culture supernatant of the strain was confirmed in the same manner as in Test Example 1, except that the test strain was changed. The results are shown in Figure 9.
[0094] As shown in Figure 9, strains NL77255, TUA7601, TUA7602, TUA7603, TUA7604, TUA7607, TUA7608, TUA7610, NL78107, NL77245, Pci9703, and TUA7605, despite exhibiting a certain degree of pathogenicity themselves, showed control titers of 50 or higher against at least one of strains NL77260, YM8302, and Pci0503, confirming a high disease suppression effect. In particular, strain TUA7602 showed a high control titer despite having a low disease severity (low pathogenicity) on its own, confirming its usefulness.
[0095] Furthermore, the supernatant polymer fractions of strains TUA7601, TUA7602, TUA7603, TUA7604, TUA7607, TUA7608, TUA7610, NL78107, NL77245, Pci9703, and TUA7605 showed bactericidal activity against strains NL77260, YM8302, and Pci0503.
Claims
1. A control agent for diseases caused by Pseudomonas cichorii, One or more bacterial cells selected from the group consisting of Pseudomonas cichorii strain NL77260 (accession number: NITE P-04366), Pseudomonas cichorii strain YM8302 (accession number: NITE P-04367), and Pseudomonas cichorii strain Pci0503 (accession number: NITE P-04368), or their culture supernatant, Pseudomonas cichorii NL77255 shares (Accession number: NITE P-04379), Pseudomonas cichorii TUA7601 shares (Accession number: NITE P-04534), Pseudomonas cichorii TUA7602 shares (Accession number: NITE P-04535), Pseudomonas cichorii TUA7603 shares (Accession number: NITE P-04536), Pseudomonas cichorii TUA7604 shares (Accession number: NITE P-04537), Pseudomonas cichorii TUA7607 (Accession number: NITE P-04538), Pseudomonas cichorii TUA7608 (Accession number: NITE P-04539), Pseudomonas cichorii TUA7610 (Accession number: NITE P-04540), Pseudomonas cichorii NL78107 (Accession number: NITE P-04532), Pseudomonas sp. NL77245 (Accession number: NITE P-04531), Pseudomonas sp. A control agent comprising one or more fungal cells or their culture supernatant selected from the group consisting of Pci9703 strain (accession number: NITE P-04533) and Pseudomonas cichorii TUA7605 strain (accession number: NITE P-04369).
2. A control agent for diseases caused by Pseudomonas cichorii, One or more bacterial cells selected from the group consisting of Pseudomonas cichorii strain NL77260 (accession number: NITE P-04366), Pseudomonas cichorii strain YM8302 (accession number: NITE P-04367), and Pseudomonas cichorii strain Pci0503 (accession number: NITE P-04368), or their culture supernatant, A control agent comprising the cells of Pseudomonas cichorii NL77255 strain (accession number: NITE P-04379) or its culture supernatant.
3. An inhibitor of plant lesions caused by infection with Pseudomonas cichorii, One or more bacterial cells selected from the group consisting of Pseudomonas cichorii strain NL77260 (accession number: NITE P-04366), Pseudomonas cichorii strain YM8302 (accession number: NITE P-04367), and Pseudomonas cichorii strain Pci0503 (accession number: NITE P-04368), or their culture supernatant, Pseudomonas cichorii NL77255 shares (Accession number: NITE P-04379), Pseudomonas cichorii TUA7601 shares (Accession number: NITE P-04534), Pseudomonas cichorii TUA7602 shares (Accession number: NITE P-04535), Pseudomonas cichorii TUA7603 shares (Accession number: NITE P-04536), Pseudomonas cichorii TUA7604 shares (Accession number: NITE P-04537), Pseudomonas cichorii TUA7607 (Accession number: NITE P-04538), Pseudomonas cichorii TUA7608 (Accession number: NITE P-04539), Pseudomonas cichorii TUA7610 (Accession number: NITE P-04540), Pseudomonas cichorii NL78107 (Accession number: NITE P-04532), Pseudomonas sp. NL77245 (Accession number: NITE P-04531), Pseudomonas sp. An inhibitor comprising one or more bacterial cells or their culture supernatant selected from the group consisting of Pci9703 strain (accession number: NITE P-04533) and Pseudomonas cichorii TUA7605 strain (accession number: NITE P-04369).
4. An inhibitor of plant lesions caused by infection with Pseudomonas cichorii, One or more bacterial cells selected from the group consisting of Pseudomonas cichorii strain NL77260 (accession number: NITE P-04366), Pseudomonas cichorii strain YM8302 (accession number: NITE P-04367), and Pseudomonas cichorii strain Pci0503 (accession number: NITE P-04368), or their culture supernatant, An inhibitor comprising the bacterial cells or culture supernatant of Pseudomonas cichorii NL77255 strain (accession number: NITE P-04379).
5. The inhibitor according to claim 3 or 4, wherein the lesion is a lesion occurring in a lettuce plant.
6. The inhibitor according to claim 3 or 4, wherein the lesion is a lesion occurring on the leaves of a lettuce plant.
7. A method for controlling diseases caused by Pseudomonas cichorii, One or more bacterial cells selected from the group consisting of Pseudomonas cichorii strain NL77260 (accession number: NITE P-04366), Pseudomonas cichorii strain YM8302 (accession number: NITE P-04367), and Pseudomonas cichorii strain Pci0503 (accession number: NITE P-04368), or their culture supernatant, Pseudomonas cichorii NL77255 shares (Accession number: NITE P-04379), Pseudomonas cichorii TUA7601 shares (Accession number: NITE P-04534), Pseudomonas cichorii TUA7602 shares (Accession number: NITE P-04535), Pseudomonas cichorii TUA7603 shares (Accession number: NITE P-04536), Pseudomonas cichorii TUA7604 shares (Accession number: NITE P-04537), Pseudomonas cichorii TUA7607 (Accession number: NITE P-04538), Pseudomonas cichorii TUA7608 (Accession number: NITE P-04539), Pseudomonas cichorii TUA7610 (Accession number: NITE P-04540), Pseudomonas cichorii NL78107 (Accession number: NITE P-04532), Pseudomonas sp. NL77245 (Accession number: NITE P-04531), Pseudomonas sp. A method comprising inoculating a plant with one or more fungal cells selected from the group consisting of Pci9703 strain (accession number: NITE P-04533) and Pseudomonas cichorii TUA7605 strain (accession number: NITE P-04369) or the culture supernatant thereof.
8. A method for controlling diseases caused by Pseudomonas cichorii, One or more bacterial cells selected from the group consisting of Pseudomonas cichorii strain NL77260 (accession number: NITE P-04366), Pseudomonas cichorii strain YM8302 (accession number: NITE P-04367), and Pseudomonas cichorii strain Pci0503 (accession number: NITE P-04368), or their culture supernatant, A method comprising inoculating a plant with the cells of Pseudomonas cichorii strain NL77255 (accession number: NITE P-04379) or its culture supernatant.
9. A method for suppressing plant lesions caused by infection with Pseudomonas cichorii, One or more bacterial cells selected from the group consisting of Pseudomonas cichorii strain NL77260 (accession number: NITE P-04366), Pseudomonas cichorii strain YM8302 (accession number: NITE P-04367), and Pseudomonas cichorii strain Pci0503 (accession number: NITE P-04368), or their culture supernatant, Pseudomonas cichorii NL77255 shares (Accession number: NITE P-04379), Pseudomonas cichorii TUA7601 shares (Accession number: NITE P-04534), Pseudomonas cichorii TUA7602 shares (Accession number: NITE P-04535), Pseudomonas cichorii TUA7603 shares (Accession number: NITE P-04536), Pseudomonas cichorii TUA7604 shares (Accession number: NITE P-04537), Pseudomonas cichorii TUA7607 (Accession number: NITE P-04538), Pseudomonas cichorii TUA7608 (Accession number: NITE P-04539), Pseudomonas cichorii TUA7610 (Accession number: NITE P-04540), Pseudomonas cichorii NL78107 (Accession number: NITE P-04532), Pseudomonas sp. NL77245 (Accession number: NITE P-04531), Pseudomonas sp. A method comprising inoculating a plant with one or more fungal cells selected from the group consisting of Pci9703 strain (accession number: NITE P-04533) and Pseudomonas cichorii TUA7605 strain (accession number: NITE P-04369) or the culture supernatant thereof.
10. A method for suppressing plant lesions caused by infection with Pseudomonas cichorii, One or more bacterial cells selected from the group consisting of Pseudomonas cichorii strain NL77260 (accession number: NITE P-04366), Pseudomonas cichorii strain YM8302 (accession number: NITE P-04367), and Pseudomonas cichorii strain Pci0503 (accession number: NITE P-04368), or their culture supernatant, A method comprising inoculating a plant with the cells of Pseudomonas cichorii strain NL77255 (accession number: NITE P-04379) or its culture supernatant.
11. The method according to claim 9 or 10, wherein the lesion is a lesion occurring in a lettuce plant.
12. The method according to claim 9 or 10, wherein the lesion is a lesion occurring on the leaves of a lettuce plant.
Citation Information
Patent Citations
Controlling agent against plant disease injury
JP1998316519A
Method for preventing disease damage to lettuce
JP2001247423A
